{"brief_title": "Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients", "brief_summary": "This study will assess an investigational medication for patients with chronic renal insufficiency (pre-dialysis) who have secondary hyperparathyroidism.", "condition": "Chronic Renal Insufficiency", "intervention_type": "Drug", "intervention_name": "cinacalcet (AMG 073)", "description": "Initially receive 1 tablet of study medication (cinacalcet or placebo) once daily. Possible sequential dose titrations are 30, 60, 90, 120, 180mg cinacalcet or placebo) daily. The titration phase was 12 weeks and the efficacy assessment phase was 6 weeks.", "arm_group_label": "cinacalcet (AMG 073)", "criteria": "Inclusion Criteria: - Patients must have chronic renal insufficiency (pre-dialysis) - Have below normal creatinine clearance - Have elevated parathyroid hormone levels Exclusion Criteria: - Pregnant or nursing - Heart attack in the last 3 months.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00042432.xml"}